You just read:

CytoSorbents Achieves Key Milestone with FDA Approval of the U.S. REFRESH 2 Pivotal Cardiac Surgery Trial IDE Application

News provided by

CytoSorbents Corporation

Dec 21, 2017, 13:58 EST